Publication | Open Access
Development and Characterization of Clinical-Grade <sup>89</sup>Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging
334
Citations
32
References
2009
Year
Clinical-grade (89)Zr-trastuzumab showed high and HER2/neu-specific tumor uptake at a good resolution.
| Year | Citations | |
|---|---|---|
Page 1
Page 1